FILTER VISION PUBLIC COMPANY LIMITED Opportunity Day : Q1.2019 May 27, 2019 At The Stock Exchange of Thailand 1
Disclaimer The information contained in this presentation is for information purposes only and does not constitute an offer or invitation to sell or the solicitation of an offer or invitation to purchase or subscribe for share in Filter Vision Public Company Limited (“FVC” and shares in FVC “shares”) in any jurisdiction nor should it or any part of it form the basis of, or be relied upon i n any connection with, any contract or commitment whatsoever. This presentation may include information which is forward-looking in nature. Forward-looking information involve known and unknown risks, uncertainties and other factors which may impact on the actual outcomes, including economic conditions in the markets in which FVC operates and general achievement of FVC business forecasts, which will cause the actual results, performance or achievements of FVC to differ, perhaps materially, from the results, performance or achievements expressed or implied in this presentation. This presentation has been prepared by FVC. The information in this presentation has not been independently verified. No representation, warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, completeness or correctness of the information and opinions in this presentation. None of FVC or any of its agents or advisers, or any of their respective affiliates, advisers or representatives, shall have any liability (in negligence or otherwise) for any loss howsoever arising from any use of this presentation or its contents or otherwise arising in connection with this presentation. This presentation is made, furnished and distributed for information purposes only. No part of this presentation shall be relied upon directly or indirectly for any investment decision-making or for any other purposes. This presentation and all other information, materials or documents provided in connection therewith, shall not, either in whole or in part, be reproduced, redistributed or made available to any other person, save in strict compliance with all applicable laws. 2
Contents Business Overview Financial Information Strategy and Outlook Q & A 3
Contents Business Overview Financial Information Strategy and Outlook Q & A 4
Business Overview FVC distribute, design, assembly, install and preventive maintenance of water treatment system and related products Industrial & OEM Commercial & Residential Medical Service B3 B1 B2 B3 (IRV) – Dialysis SOL N , Water and Facility for Hemodialysis ( HD ) B3 ( KTMS) – Hemodialysis Center B3 (MV) – Pneumatic Tube System B3 (HHC) – Healthcare and aesthetics 5
Business Overview B1 : Industrial and OEM Semi Automatic Water Purifier Reverse Osmosis System Automatic Regenerate Softener Filter 6
Business Overview B1 : Industrial and OEM Zero Discharge Wastewater Treatment System Ultra Filtration 7
Business Overview B1 : Industrial and OEM Bio-Well for Dental Bio-Well for Dental 8
Business Overview B2 : Commercial and residential UV System Prefilter R30-BB+7FC Triple+Claris L 9
Business Overview B2 : Commercial and residential RO system + Everpure High flow triple Water system for drinking water and ice machine 10
Business Overview B2 : Commercial and residential Nitro-Coffee Water INT 11
Business Overview B3 : Medical service IRVING CORPORATION LIMITED Pure Water Treatment System for HD Decoration for HD 12
Business Overview B3 : Medical service IRVING CORPORATION LIMITED Chemical Hood Dialysate Solution Dialyzer Cabinet 13
Business Overview B3 : Medical service KT MEDICAL SERVICE COMPANY LIMITED KT Medical Service Hemodialysis Center 14
Business Overview B3 : Medical service MEDICAL VISION COMPANY LIMITED Pneumatic Tube System 15
Business Overview B3 : Medical service HI HEALTHCARE CENTER COMPANY LIMITED Healthcare and aesthetics clinic under trademark “ Wuttisak Clinic” 16
Customer Segments Industrial & OEM (B1) 17
Customer Segments Commercial & Residential (B2) 18
Customer Segments Commercial & Residential (B2) 19
Customer Segments Medical Service ( B3) 20
Content Business Overview Financial Information Strategy and Outlook Q & A 21
Financial Information Revenue Q1 ’ 19 Revenue Breakdown Bt. mil 656.71 700 459.26 B1 600 394.31 21% B3 364.91 500 360.75 43% 400 B2 36% 182.43 300 144.09 200 100 Q1 ’ 18 Revenue Breakdown 0 2014 2015 2016 2017 2018 Q1'2018 Q1'2019 B1 increase/ 11% (Bt.mil) Q1’2018 Q1’2019 % decrease B3 B1 16.43 37.27 20.84 126.84% 46% B2 B2 62.13 66.10 3.97 6. 39% 43% B3 65.53 79.06 13.53 20.65% Total 144.09 182.43 38.34 2 6.61% 22
Financial Information Gross Profit Margin QoQ 4.74% 31.64% 28.59% 27.21% 27.94% 26.34% 20.42% 19.11% 15.68% 2013 2014 2015 2016 2017 2018 Q1'18 Q1'19 Gross Profit Margin 23
Financial Information SG&A YE18 SG&A Breakdown (Bt.mil) QoQ Professional 36.37 31.11 32.53 33.44 33.76 31.11 Others 16.91% 6% 8% 8.24 Depreciation 8% 7.44 7.68 7.84 7.64 7.64 Office expense 7% Personnel 68% Traveling 19.19 3% 17.83 17.42 17.62 17.32 17.32 SG&A was increased by 16.91 % : 8.94 Mainly came from expenses which were 8.49 8.34 7.07 6.15 6.15 increased from HHC and Annual adjust Q1'18 Q2'18 Q3'18 Q4'18 Q1'18 Q1'19 base salaries from others companies 24 Selling Admin Management
Financial Information Net Profit & Net Profit Margin (Bt.mil) % 0.00% -0.05% 22.00 -0.59% QoQ 17.00 4.32 % -1.00% 12.00 AMOUNT -2.00% 7.00 QoQ 2.00 6.21 (0.09) -3.00% 1Q18 2Q18 3Q18 4Q18 1Q18 1Q19 (3.00) -3.55% ( 6.30 ) (6.30) ( 3.88 ) (8.00) -3.76% -4.00% ( 10.95 ) -4.37% (13.00) -4.37% ( 17.87 ) (18.00) -5.00% Net Profit Net Profit Margin Net Loss was decreased from Q1'2018 around 4.32% mainly came from Sale and Service income from every business was continuously grow up. 25
Financial Information Balance Sheet (Bt.mil) 900 Asset Equity Liabilities 800 283.75 309.33 123.43 700 600 954.82 980.31 500 787.13 107.94 400 671.07 670.98 663.70 70.72 300 466.93 407.05 71.96 76.97 358.99 336.33 275.40 285.95 200 203.44 208.98 100 2013 2014 2015 2016 2017 2018 Q1'19 26
Financial Information ROA -0.04% 1Q18 2Q18 3Q18 4Q18 4Q18 1Q19 -0.45% -0.45% ROA & ROE QoQ was increased from 0.4 1 % Revenue of Group's business. -2.63% -2.86% -3.11% ROE -0.06% 1 Q 18 1 Q 18 3 Q 18 4 Q 18 4 Q 18 1 Q 19 -0.58% -0.58% QoQ 0.52% -3.30% -3.61% -3.82% 27
Financial Information D/E 0.46 0.42 QoQ 0.42 0. 04 % 0.34 0.32 0.27 1Q18 1Q18 3Q18 4Q18 4Q18 1Q19 28
Content Business Overview Financial Information Strategy and Outlook Q & A 29
FVC Road Map Food & Beverage Medical Service 2015 Expand market to Medical Service - Capital Increased to 195 MB. Sector . - Purchase land for new office and warehouse (BKK). 2014 Restructure Technical Service Department “Water Treatment” & “Food Equipment”. 2013 IPO on October 29, 2013. 30
FVC Road Map Food & Beverage Medical Service 2018 - Capital Increased to 355.50 MB. - Entered into franchisee of “ Wuttisak Clinic ”. - Start with new office and warehouse (BKK). - New Local Marketing & Operation in - Launching New Products ; Water INT and Nitro healthcare and esthetics business. Coffee. - Exercise the 63 HD machines. - Re-positioning in Industrial and OEM (B1) - Prepare the building in North to operate the - Recognize income from improve wastewater new hemodialysis center in 2019. 2017 treatment systems. - Operated 2 new branch of Hemodialysis - Purchase land in Chiang Mai. Center. - Capital increased to 342.79 MB. - On-line Hemodiafiltration. - Special project for discount store. - Capital increased to 40.00 MB. (KTMS) - Water treatment for dental. - Entered MOU with “ Wuttisak Clinic”. 2016 Operated Hemodialysis Center and Pneumatic Tube System. 31
FVC Road Map Corporate - Announce New Vision, Mission and Core Value. 2019 - Implement the ERP system for business. Food & Beverage - Contract in wastewater treatment systems (expected to be over than income budget). - Recognize income from Water Int. Pad in North. - Engagement a Water Int. Pad in new organization. - Operated 3 new branch of hemodialysis unit and Medical Service exercise new 55 HD Machines . - Recognized income from Pneumatic Tube System in first quarter approximately 10.00 MB. - Expending business in dialysis SOL N and water and facility for hemodialysis(HD). - Local strategic program for healthcare and aesthetics. 32
FVC Road Map : Plan 2020 - 2022 • Balancing The Business’s Portfolio. • Uniformed Employer & Employee Branding. Corporate • Supply Chain Mgmt. : Central operation center, Utilities' Mgmt. • Projected to spin-off Medical Service to mai in 2021. B1 • Sale Target : 150-200 MB. In 2022 Sale force management • Contractor and O&M for WTP and WWTP. Industrial & • Green & Energy Saving Technology for Special Application. OEM • R & D resources for FVC . 33
Recommend
More recommend
